E Fund Management »

Protagonist Therapeutics shares owned by E Fund Management

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by E Fund Management from 13F filings

Historical chart of E Fund Management investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by E Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by E Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $16k 156 105.40

More positions owned by E Fund Management

iShares Core S&P 500 ETF Core S&p500 Etf (IVV)
PDD Holdings Sponsored Ads (PDD)
NVIDIA Corporation (NVDA)
State Street SPDR S&P 500 ETF Tr Unit (SPY)
Apple (AAPL)
Yum China Holdings (YUMC)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Newmont Mining Corporation (NEM)
Broadcom (AVGO)
H World Group Sponsored Ads (HTHT)
Meta Platforms Cl A (META)
Agnico (AEM)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for E Fund Management

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Vanguard Group
UBS Group
Rtw Investments
Vanguard Portfolio Management
State Street Corporation
Wellington Management Company
Henderson Group
Johnson & Johnson
Invesco
Geode Capital Management
Citadel Advisors
Woodline Partners
Bank of America Corporation

View all funds holding Protagonist Therapeutics